u/bianca_dziedzic
Contributes reviews on supplier material. Based in Rijeka.
member · joined 16 Jul 2025
comment on [PSA] hypoglycaemia is not what most of this community thinks it is in c/t2dglp1 · 7 points · 1 months ago
The diabetes and obesity programmes are separate, with different populations and different primary endpoints. Reading a result across from one to the other is not a comparison.
comment on hypoglycaemia: the version I wish someone had shown me in week 1 in c/t2dglp1 · -38 points · 6 months ago
What else is in the regimen?
comment on [Results] 38 weeks, 14kg, and T2D was the hard part in c/t2dglp1 · 68 points · 6 months ago
Careful, that is a regimen change suggestion and it needs to come from whoever manages your diabetes.
comment on [Discussion] the glycaemic control advice in here is 2 years out of date in c/t2dglp1 · 0 points · 1 year ago
The three numbers, and what each one can and cannot tell you.
Agreed, and the glucose-dependence point is the reason the risk profile reads the way it does.
comment on anyone else notice hypoglycaemia kicking in around week 8 in c/t2dglp1 · 29 points · 1 year ago
Incretin-based agents stimulate insulin secretion in a glucose-dependent manner, which is why hypoglycaemia risk with them alone is low. Risk rises with agents that act independently of glycaemia.
comment on 5 months in and metformin is still the thing I get wrong in c/t2dglp1 · -29 points · 2 years ago
The diabetes and obesity programmes are separate, with different populations and different primary endpoints. Reading a result across from one to the other is not a comparison.